Bevacizumab/Cisplatin/Paclitaxel/Pembrolizumab Regimen

Preferred Label : Bevacizumab/Cisplatin/Paclitaxel/Pembrolizumab Regimen;

NCIt synonyms : Bevacizumab-Cisplatin-Paclitaxel-Pembrolizumab; Bevacizumab/Cisplatin/Paclitaxel/Pembrolizumab; Paclitaxel/Cisplatin Plus Pembrolizumab/Bevacizumab; Avastin/Cisplatin/Taxol/Keytruda;

NCIt related terms : Cisplatin, Paclitaxel, Bevacizumab, Pembrolizumab; Cisplatin, Paclitaxel, Bevacizumab-adcd, Pembrolizumab; Cisplatin, Paclitaxel, Bevacizumab-awwb, Pembrolizumab; Cisplatin, Paclitaxel, Bevacizumab-maly, Pembrolizumab; Cisplatin, Paclitaxel, Bevacizumab-bvzr, Pembrolizumab; Cisplatin, Paclitaxel, Bevacizumab-equi, Pembrolizumab; Cisplatin, Paclitaxel, Bevacizumab-onbe, Pembrolizumab; Cisplatin, Paclitaxel, Bevacizumab-aybi, Pembrolizumab;

NCIt definition : A regimen consisting of bevacizumab, cisplatin, paclitaxel and pembrolizumab that may be used in the treatment of cervical and vaginal cancer.;

NCI Metathesaurus CUI : CL1927615;

Codes from synonyms : 65366; 127612; 127390; 127464; 127242; 127316; 127168; 127538;

Details

Origin ID

C205356;

chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Cisplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Cervical Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients